Screening versus multidimensional assessment of symptoms and psychosocial distress in cancer patients from the time of incurability.
cancer patients
multidimensional assessment
palliative medicine
quality of life
screening
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2023
2023
Historique:
received:
25
07
2022
accepted:
10
01
2023
entrez:
13
2
2023
pubmed:
14
2
2023
medline:
14
2
2023
Statut:
epublish
Résumé
Previous symptom prevalence studies show a diverse spectrum of symptoms and a large diversity in symptom intensities in patients being just diagnosed as having incurable cancer. It is unclear, how physical symptoms and psychosocial burden should be recorded in order to determine the variable need for palliative care and further support. Therefore, we compared two different strategies for detecting physical symptoms and psychosocial burden of patients with newly diagnosed incurable cancer and their effects on the further course of the disease. SCREBEL is a controlled, randomized, non-blinded, longitudinal study of the research network of the Palliative Medicine Working Group (APM) of the German Cancer Society (DKG). We compared: a less complex repeated brief 504 patients were included in the study. 262 patients were lost to follow-up, including 155 fatalities. There were no significant differences between the low-threshold A comprehensive, multidimensional
Identifiants
pubmed: 36776341
doi: 10.3389/fonc.2023.1002499
pmc: PMC9908949
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1002499Informations de copyright
Copyright © 2023 Solar, Wieditz, Lordick, Mehnert-Theuerkauf, Oechsle, van Oorschot, Thomas, Asendorf, Nauck and Alt-Epping.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
J Patient Rep Outcomes. 2021 Jan 28;5(1):15
pubmed: 33507419
Support Care Cancer. 2018 Sep;26(9):3063-3071
pubmed: 29564622
Am J Hosp Palliat Care. 2008 Dec-2009 Jan;25(6):501-11
pubmed: 19106284
J Clin Oncol. 2016 Feb 20;34(6):557-65
pubmed: 26644527
J Gen Intern Med. 2020 May;35(5):1559-1566
pubmed: 31637653
N Engl J Med. 2010 Aug 19;363(8):733-42
pubmed: 20818875
Oncol Res Treat. 2016;39(4):186-91
pubmed: 27160588
Oncologist. 2021 Jun;26(6):e1058-e1065
pubmed: 33687742
Age Ageing. 2005 May;34(3):218-27
pubmed: 15863407
J Pain Symptom Manage. 2005 Jul;30(1):51-62
pubmed: 16043007
Heart Fail Rev. 2021 Jan;26(1):137-155
pubmed: 32748015
Support Care Cancer. 2012 Oct;20(10):2415-24
pubmed: 22212457
Hematology Am Soc Hematol Educ Program. 2020 Dec 4;2020(1):148-153
pubmed: 33275720
J Pain Symptom Manage. 2019 Nov;58(5):886-890.e5
pubmed: 31330287
Arch Intern Med. 2012 Aug 13;172(15):1133-42
pubmed: 22777380
Psychooncology. 2014 Mar;23(3):241-50
pubmed: 25160838
J Clin Oncol. 2017 Mar 10;35(8):834-841
pubmed: 28029308
JAMA. 2016 Nov 22;316(20):2094-2103
pubmed: 27893130
Palliat Med. 2014 Apr;28(4):302-11
pubmed: 24403380
Psychooncology. 2021 Jul;30(7):1029-1040
pubmed: 33728728
Patient Educ Couns. 2022 Apr;105(4):982-986
pubmed: 34384640
J Affect Disord. 2010 Apr;122(1-2):86-95
pubmed: 19616305
Eval Health Prof. 2005 Jun;28(2):192-211
pubmed: 15851773
JAMA. 2017 Jul 11;318(2):197-198
pubmed: 28586821
Palliat Med. 2016 Jun;30(6):599-610
pubmed: 26415736
J Clin Oncol. 2011 Feb 20;29(6):646-50
pubmed: 21263094
J Clin Oncol. 1993 Mar;11(3):570-9
pubmed: 8445433